Atlas Trials

The Safety and Efficacy of Intralymphatic Immunotherapy in Pollen Allergic Adolescents and Young Adults With Asthma

Clinical trial NCT03394508 · COMPLETED

Trial details

NCT number
NCT03394508
Sponsor
Karolinska Institutet
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
RhinitisAsthmaAllergy
Start date
2013-01-01
Primary completion
2017-12-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.